PUBLISHER: IMARC | PRODUCT CODE: 1922704
PUBLISHER: IMARC | PRODUCT CODE: 1922704
The Japan pharmacy retail market size reached USD 120.6 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 191.3 Billion by 2034 , exhibiting a growth rate (CAGR) of 5.26% during 2026-2034 . The aging population with increasing chronic conditions, a shift towards home healthcare and digital services, government support through national insurance programs, and technological advancements in automation and online sales are among the key factors contributing to the market expansion.
Aging Population and Increase in Chronic Conditions
A major growth driver of Japan's pharmacy retail market is the country's rapidly aging population, one of the fastest-aging globally. As of 2023, over 28% of Japan's population was aged 65 or older, and this figure is expected to exceed 30% by 2025. This demographic shift is significantly increasing demand for healthcare services and pharmacy-related products. According to the Ministry of Health, Labor and Welfare, a growing share of adults aged 65 and above in Japan suffer from chronic conditions, such as diabetes, hypertension, and cardiovascular diseases, leading to a steady rise in prescription medication needs. Elderly consumers increasingly depend on pharmacies not only for prescriptions but also for over-the-counter drugs, wellness products, health consultations, and preventive care. Supporting this trend is Japan's robust National Health Insurance (NHI) system, which covered over 96% of the population in 2023, making healthcare, including pharmacy services, both accessible and affordable. Retail pharmacies are evolving into comprehensive health management hubs, offering home delivery, medication counseling, and advanced pharmaceutical care tailored to the needs of aging consumers.
To get more information on this market Request Sample
Technological Advancements and E-Pharmacy Growth
Technological advancements and the rise of e-pharmacies are also reshaping Japan's pharmacy retail market, driving substantial growth. In recent years, Japanese consumers have increasingly turned to digital platforms, including online pharmacies and health apps, to access medications and healthcare services more conveniently. This digital shift, accelerated by the COVID-19 pandemic, has seen more consumers opting for remote consultations and ordering prescription drugs and over the counter (OTC) products online. Japan's e-pharmacy market size reached USD 6.4 billion in 2024 and is expected to reach USD 20.5 billion by 2033, exhibiting a growth rate (CAGR) of 12.4% during 2025-2033, driven by innovations in digital health technologies and growing consumer demand for convenience. E-pharmacies enable consumers to order medications from home, receive digital prescriptions, and access telemedicine consultations. Government support for digital health services, including the introduction of digital prescriptions and online consultations in 2023, has further fueled this transition. Additionally, automation and robotics in physical pharmacies, such as automated dispensing systems and robot-assisted operations, have improved service speed and accuracy, reduced wait times, and enhanced customer satisfaction.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.